Literature DB >> 11702212

Scanning for telomeric deletions and duplications and uniparental disomy using genetic markers in 120 children with malformations.

M J Rosenberg1, C Killoran, L Dziadzio, S Chang, D L Stone, J Meck, D Aughton, L M Bird, J Bodurtha, S B Cassidy, J M Graham, A Grix, A E Guttmacher, L Hudgins, C Kozma, R C Michaelis, R Pauli, K F Peters, K N Rosenbaum, C J Tifft, D Wargowski, M S Williams, L G Biesecker.   

Abstract

We screened 120 children with sporadic multiple congenital anomalies and either growth or mental retardation for uniparental disomy (UPD) or subtelomeric deletions. The screening used short tandem repeat polymorphisms (STRP) from the subtelomeric regions of 41 chromosome arms. Uninformative marker results were reanalyzed by using the next available marker on that chromosome arm. In total, approximately 25,000 genotypes were generated and analyzed for this study. Subtelomeric deletions of 1 Mb in size were excluded for 27 of 40 chromosome arms. Among the 120 subjects none was found to have UPD, but five subjects (4%, 95% confidence interval 1-9%) were found to have a deletion or duplication of one or more chromosome arms. We conclude that UPD is not a frequent cause of undiagnosed multiple congenital anomaly syndrome. In addition, we determined that 9p and 7q harbor chromosome length variations in the normal population. We conclude that subtelomeric marker analysis is effective for the detection of subtelomeric duplications and deletions, although it is labor intensive. Given a detection rate that is similar to prior studies and the large workload imposed by STRPs, we conclude that STRPs are an effective, but impractical, approach to the determination of segmental aneusomy given current technology.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11702212     DOI: 10.1007/s004390100559

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  7 in total

Review 1.  Telomeres: a diagnosis at the end of the chromosomes.

Authors:  B B A De Vries; R Winter; A Schinzel; C van Ravenswaaij-Arts
Journal:  J Med Genet       Date:  2003-06       Impact factor: 6.318

2.  "Familial" versus "sporadic" intellectual disability: contribution of subtelomeric rearrangements.

Authors:  Maryam Rafati; Mohammad R Ghadirzadeh; Yaser Heshmati; Homeira Adibi; Zarrintaj Keihanidoust; Mohammad R Eshraghian; Jila Dastan; Azadeh Hoseini; Marzieh Purhoseini; Saeed R Ghaffari
Journal:  Mol Cytogenet       Date:  2012-01-19       Impact factor: 2.009

3.  Subtelomeric rearrangements in idiopathic mental retardation.

Authors:  Gopalrao V N Velagaleti; Sally S Robinson; Bobby M Rouse; Vijay S Tonk; Lillian H Lockhart
Journal:  Indian J Pediatr       Date:  2005-08       Impact factor: 1.967

4.  Detection of genomic imbalances by array based comparative genomic hybridisation in fetuses with multiple malformations.

Authors:  C Le Caignec; M Boceno; P Saugier-Veber; S Jacquemont; M Joubert; A David; T Frebourg; J M Rival
Journal:  J Med Genet       Date:  2005-02       Impact factor: 6.318

5.  Automated fluorescent genotyping detects 10% of cryptic subtelomeric rearrangements in idiopathic syndromic mental retardation.

Authors:  M Rio; F Molinari; S Heuertz; C Ozilou; P Gosset; O Raoul; V Cormier-Daire; J Amiel; S Lyonnet; M Le Merrer; C Turleau; M-C de Blois; M Prieur; S Romana; M Vekemans; A Munnich; L Colleaux
Journal:  J Med Genet       Date:  2002-04       Impact factor: 6.318

6.  Prospective screening for subtelomeric rearrangements in children with mental retardation of unknown aetiology: the Amsterdam experience.

Authors:  C D M van Karnebeek; C Koevoets; S Sluijter; E K Bijlsma; D F M C Smeets; E J Redeker; R C M Hennekam; J M N Hoovers
Journal:  J Med Genet       Date:  2002-08       Impact factor: 6.318

7.  Molecular characterisation of the 22q13 deletion syndrome supports the role of haploinsufficiency of SHANK3/PROSAP2 in the major neurological symptoms.

Authors:  H L Wilson; A C C Wong; S R Shaw; W-Y Tse; G A Stapleton; M C Phelan; S Hu; J Marshall; H E McDermid
Journal:  J Med Genet       Date:  2003-08       Impact factor: 6.318

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.